Sign in

CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company

CURIS INC

Sign in to watch
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
043505116
Phone
617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 8-K Event Executive or director change · Other events
  11. 4 Option exercise Director acquired 12,900 shares (option exercise)
  12. 4 Open-market sale Director sold 25,600 shares at an average $2.97 ($75,936)
  13. 4 Open-market sale Director sold 13,600 shares at an average $2.85 ($38,780)
  14. 4 Open-market sale Director sold 48,900 shares at an average $2.78 ($136,110)
  15. 4 Open-market sale Director sold 289,000 shares at an average $2.99 ($863,450)
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations · Executive or director change
  18. EFFECT Other Notice of Effectiveness
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. S-3/A Offering Registration Statement

Page 25 of 61 · 1,213 filings